• July/August 2025 – Contents

  • Patient voice: Shaping the future of medicine regulation

  • ​The evolving landscape of Public and Patient Involvement

  • Patient involvement in the regulatory area: Insights into national level dialogues

  • ​The importance of patient advocacy in the EMA ODD process

  • ​Realising opportunities to generate RWE for regulatory decisions through randomised pragmatic trials

  • ​Diversity in clinical research: Regulatory considerations and updates

  • FDA comparability guidance: The impact of cell and gene therapy products

TOPRA FAMHP Podcast 800x533px (6.4 ratio) V1

RegRapPodInConversation with Hugues Malonne

2025-06-18T16:55:00+01:00By , , , and

InConversation talks about the role of the Federal Agency for Medicines and Health Products (FAMHP) with Hugues Malonne, Chief Executive Officer at FAMHP

TOPRA VetReg Podcast 800x533px (6.4 ratio)

RegRapPodInConversation with Ivo Claassen

2025-04-07T08:30:00+01:00By and

InConversation talks veterinary regulation with Ivo Claassen, Head of the Veterinary Medicines Division at the EMA